Healthcare Services Group, Inc. (HCSG)
NASDAQ: HCSG · Real-Time Price · USD
10.55
-0.23 (-2.13%)
Feb 21, 2025, 4:00 PM EST - Market closed
Healthcare Services Group Market Cap
Healthcare Services Group has a market cap or net worth of $775.30 million as of February 21, 2025. Its market cap has increased by 14.11% in one year.
Market Cap
775.30M
Enterprise Value
684.44M
1-Year Change
14.11%
Ranking
Category
Stock Price
$10.55
Market Cap Chart
Since December 1, 1998, Healthcare Services Group's market cap has increased from $99.70M to $775.30M, an increase of 677.63%. That is a compound annual growth rate of 8.13%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 775.30M | -8.93% |
Dec 31, 2024 | 851.30M | 11.16% |
Dec 29, 2023 | 765.80M | -13.87% |
Dec 30, 2022 | 889.10M | -32.95% |
Dec 31, 2021 | 1.33B | -36.59% |
Dec 31, 2020 | 2.09B | 16.02% |
Dec 31, 2019 | 1.80B | -39.21% |
Dec 31, 2018 | 2.97B | -23.24% |
Dec 29, 2017 | 3.86B | 35.87% |
Dec 30, 2016 | 2.84B | 13.30% |
Dec 31, 2015 | 2.51B | 14.80% |
Dec 31, 2014 | 2.19B | 10.38% |
Dec 31, 2013 | 1.98B | 25.86% |
Dec 31, 2012 | 1.57B | 33.25% |
Dec 30, 2011 | 1.18B | 10.13% |
Dec 31, 2010 | 1.07B | 14.92% |
Dec 31, 2009 | 933.10M | 36.20% |
Dec 31, 2008 | 685.10M | -23.99% |
Dec 31, 2007 | 901.30M | 13.37% |
Dec 29, 2006 | 795.00M | 42.70% |
Dec 30, 2005 | 557.10M | 45.12% |
Dec 31, 2004 | 383.90M | 74.90% |
Dec 31, 2003 | 219.50M | 47.51% |
Dec 31, 2002 | 148.80M | 32.38% |
Dec 31, 2001 | 112.40M | 61.26% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 784.71B |
UnitedHealth Group | 429.24B |
Novo Nordisk | 391.83B |
Johnson & Johnson | 390.76B |
AbbVie | 356.74B |
Abbott Laboratories | 234.01B |
AstraZeneca | 229.50B |
Merck & Co. | 226.40B |